• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Product Image

The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses

  • Published: August 2010
  • 96 Pages
  • Scripp Business Insights

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cordis
  • Edwards Lifesciences
  • Medtronic
  • Other major companies,
  • MORE

The cardiovascular (CV) device industry is highly competitive and has reached maturity resulting in single digit growth rates of prominent devices such as pacemakers, defibrillators, and drug eluting stents (DES). Innovations in niche sectors such as atrial fibrillation (AF) and ventricular assist devices (VADs) are poised for double digit growth in the near to mid-term future. From 2007–09, the top three companies in the CV segment acquired other smaller firms to expand their product portfolios and to gain market share in new geographies. Some major companies also established manufacturing facilities outside the US to enhance cost containment and product distribution. The CV device market remained relatively resilient during the economic downturn compared with other healthcare segments. The 2007–09 period also witnessed a considerable rise in consolidation activities among major companies.

This report provides detailed profiles of the top 10 cardiovascular (CV) device companies and brief profiles of other major players. It also elucidates trends within the cardiovascular device market. The detailed profiles contain descriptions of business, financial performance, READ MORE >

Chapter 1 Introduction
- What is this report about?
- Methodology

Chapter 2 Industry overview
- Summary
- Introduction
- Market size and growth
- Key drivers and resistors
- Drivers of growth
- Resistors of growth
- Competitive landscape
- The top 10 companies
- Market characteristics
- CV industry trends
- Pricing pressures due to industry regulations
- Significance of CV device innovation
- Decline in capital expenditure of hospitals
- Cost containment challenges

Chapter 3 Medtronic
- Summary
- Company overview
- Financial performance
- Financial performance by segments
- Cardiac rhythm management
- Cardiovascular
- Physio-control
- Marketed products
- Cardiac rhythm management
- Cardiovascular
- Physio-control
- Recent product approvals
- Challenges
- Litigations
- Growth strategies
- Research and development
- Acquisitions
- Analysis of growth strategies
- Marketing and sales strategies
- SWOT analysis - Medtronic

Chapter 4 Boston Scientific
- Summary
- Company overview
- Financial performance
- Marketed products
- Recently launched products and approvals
- Challenges
- Litigations
- Growth strategies
- Research and development
- Analysis of growth strategies
- SWOT analysis - Boston Scientific

Chapter 5 St. Jude Medical
- Summary
- Company overview
- Financial performance
- Financial performance by segments
- Marketed products
- Recent approvals and product launches
- Growth strategies
- Research and development
- Analysis of growth strategies
- SWOT analysis - St. Jude Medical

Chapter 6 Abbott Laboratories
- Summary
- Company overview
- Financial performance
- Marketed products
- Recent approvals and product launches
- Growth strategies
- Acquisitions and divestments
- Analysis of growth strategies
- SWOT analysis - Abbott Laboratories

Chapter 7 Cordis
- Summary
- Company overview
- Financial performance
- Marketed products
- Recent approvals and product launches
- Challenges
- Litigations
- Growth strategies
- Research and development
- Analysis of growth strategies
- SWOT analysis - Cordis

Chapter 8 Terumo
- Summary
- Company overview
- Financial performance
- Marketed products
- Recent approvals and product launches
- Growth strategies
- Research and development
- Analysis of growth strategies
- SWOT analysis - Terumo

Chapter 9 Edwards Lifesciences
- Summary
- Company overview
- Financial performance
- Financial performance by segments
- Heart valve therapy
- Cardiac surgery systems
- Vascular
- Marketed products
- Recent approvals and product launches
- Challenges
- Litigations
- Growth strategies
- Research and development
- Analysis of growth strategies
- SWOT analysis - Edwards Lifesciences

Chapter 10 Sorin
- Summary
- Company overview
- Financial performance
- Financial performance by segments
- Marketed products
- Recent approvals and product launches
- Growth strategies
- Analysis of growth strategies
- SWOT analysis - Sorin

Chapter 11 Zoll Medical
- Summary
- Company overview
- Financial performance
- Marketed products
- Recent approvals and product launches
- Growth strategies
- Research and development
- Analysis of growth strategies
- SWOT analysis - Zoll Medical

Chapter 12 Thoratec
- Summary
- Company overview
- Financial performance
- Marketed products
- Recent approvals and product launches
- Growth strategies
- Research and development
- Analysis of growth strategies
- SWOT analysis - Thoratec

Chapter 13 Other major players
- Merit Medical Systems
- ATS Medical
- Biotronik
- Appendix
- Abbreviations
- Definitions

List of Figures

Figure 1: CV device global market performance, 2007–2009
Figure 2: Revenues of top 10 CV companies ($m), 2007-2009
Figure 3: Medtronic CV device revenue performance, 2007–09
Figure 4: SWOT analysis – Medtronic
Figure 5: Boston Scientific CV device revenue performance, 2007–09
Figure 6: SWOT analysis – Boston Scientific
Figure 7: St. Jude Medical CV device revenue performance, 2007–09
Figure 8: SWOT analysis – St. Jude Medical
Figure 9: Abbott Laboratories CV device revenue performance, 2007–09
Figure 10: SWOT analysis – Abbott Laboratories
Figure 11: Cordis CV device revenue performance, 2007–09
Figure 12: SWOT analysis – Cordis
Figure 13: Terumo CV device revenue performance, 2007–09
Figure 14: SWOT analysis – Terumo
Figure 15: Edwards Lifesciences CV device revenue performance, 2007–09
Figure 16: SWOT analysis – Edwards Lifesciences
Figure 17: Sorin CV device revenue performance, 2007–09
Figure 18: SWOT analysis – Sorin
Figure 19: Zoll Medical CV device revenue performance, 2007–09
Figure 20: SWOT analysis – Zoll
Figure 21: Thoratec CV device revenue performance, 2007–09
Figure 22: SWOT analysis – Thoratec
Figure 23: Merit Medical Systems CV device revenue performance, 2007–09
Figure 24: ATS Medical CV device revenue performance, 2007–09

List of Tables

Table 1: CV device global market performance, 2007–2009
Table 2: Revenues of top 10 cardiovascular companies ($m), 2007-2000
Table 3: Global market shares of the top 10 CV device companies, 2009
Table 4: R&D expenditure of top 3 CV device companies, 2009
Table 5: Global market size of prominent CV device segments, 2009
Table 6: Medtronic CV device revenue performance, 2007–09
Table 7: Medtronic product portfolio
Table 8: Boston Scientific CV device revenue performance, 2007–09
Table 9: Boston Scientific product portfolio
Table 10: St. Jude Medical CV device revenue performance, 2007–09
Table 11: St. Jude Medical product portfolio
Table 12: Abbott Laboratories CV device revenue performance, 2007–09
Table 13: Abbott Laboratories product portfolio
Table 14: Cordis CV device revenue performance, 2007–09
Table 15: Cordis product portfolio
Table 16: Terumo CV device revenue performance, 2007–09
Table 17: Terumo product portfolio
Table 18: Edwards Lifesciences CV device revenue performance, 2007–09
Table 19: Edwards Lifesciences product portfolio
Table 20: Sorin CV device revenue performance, 2007–09
Table 21: Sorin product portfolio
Table 22: Zoll Medical CV device revenue performance, 2007–09
Table 23: Zoll Medical product portfolio

- Abbott Laboratories
- Boston Scientific
- Cordis
- Edwards Lifesciences
- Medtronic
- Sorin Group
- St. Jude Medical
- Terumo
- Thoratec
- Zoll
- Other major companies,

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos